Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Needham Downgrades Analog Devices to Hold

Needham Downgrades Analog Devices to Hold

Needham analyst Quinn Bolton downgrades Analog Devices (NASDAQ:ADI) from Buy to Hold.

byBenzinga Newsdesk

August 18, 2022

1 minute read

Needham analyst Quinn Bolton downgrades Analog Devices (NASDAQ:ADI) from Buy to Hold.

Analyst Ratings

Where Carlisle Companies Stands With Analysts

By Benzinga Insights

May 1, 3:00 PM

Within the last quarter, Carlisle Companies (NYSE:CSL) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…

CSL

Skillsoft Corp. Class A Common Stock Q2 Sales $140.57M Miss $184.63M Estimate

By Michael Horton

September 7, 4:20 PM

Skillsoft Corp. Class A Common Stock (NYSE:SKIL) reported quarterly sales of $140.57 million which missed the analyst consensus estimate of $184.63 million by 23.86 percent.

SKIL

FDA
News

Co-Diagnostics Announces Shipment Of Monkeypox Virus Test

By Benzinga Newsdesk

July 11, 9:30 AM

Co-Diagnostics, Inc. (NASDAQ:CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that

CODX

CTI BioPharma Q4 EPS $(0.14) Vs $(0.38) Last Year, Sales $21.10M Miss $23.67M Estimate

By Benzinga Newsdesk

March 6, 7:28 AM

CTI BioPharma (NASDAQ:CTIC) reported quarterly losses of $(0.14). This is a 63.16 percent increase over losses of $(0.38) per share from the same period last year. The company reported quarterly sales of $21.10 million

CTIC

Needham Downgrades Analog Devices to Hold

Related Posts

Where Carlisle Companies Stands With Analysts

Skillsoft Corp. Class A Common Stock Q2 Sales $140.57M Miss $184.63M Estimate

Co-Diagnostics Announces Shipment Of Monkeypox Virus Test

CTI BioPharma Q4 EPS $(0.14) Vs $(0.38) Last Year, Sales $21.10M Miss $23.67M Estimate